跳至主要内容
临床试验/JPRN-jRCTs072180045
JPRN-jRCTs072180045已完成2 期

The study on the efficacy and the mechanism of repetitive transcranial magnetic stimulation (rTMS) for mood disorders - rTMS trial for mood disorders

Tateishi Hiroshi0 个研究点目标入组 34 人开始时间: 2019年3月14日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
34

研究概览

简要总结

rTMS treatment significantly improved depressive symptom scores and some subscales of cognitive dysfunction. The partial improvement of cognitive function and the decrease of serum IL-1beta showed a significant correlation.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • 1.Patients with major depression or bipolar disorders who were ineffective for the treatment of more than one antidepressants
  • 2.Written informed consent

排除标准

  • Absolute contraindications are patients with metals in the brain, patients with intracardiac catheters, patients with high intracardiac pressure. Relative contraindications are epilepsy patients, patients with a history of intracranial lesions, oral history of drugs that reduce convulsion threshold, sleep deprivation, alcohol dependence, pregnant women, children, patients with severe heart disease. Regarding cerebrospinal fluid examination, patients with high risk such as bleeding tendency, heparin use, anesthesia allergy, cerebral hypertension etc., or patients judged inappropriate by the psychiatrist.

研究者

发起方
Tateishi Hiroshi

相似试验

The study on the efficacy and the mechanism of... | 临床试验